急性缺血性卒中静脉阿替普酶溶栓后出血转化的治疗与结局:美国心脏协会/美国卒中协会科学声明
该科学声明由美国心脏协会/美国卒中协会制定,通过文献综述总结症状性颅内出血(sICH)的定义、流行病学、危险因素、病理生理、治疗与结局,指出sICH是静脉阿替普酶溶栓少见但严重的并发症,及时诊断和早期纠正凝血障碍是治疗基石,需进一步研究血脑屏障保护治疗。
要点
- sICH是急性缺血性卒中静脉阿替普酶溶栓少见但严重的并发症。
- 及时诊断和早期纠正溶栓后凝血障碍是sICH治疗的主要手段。
- 需进一步研究基于抑制 underlying 生化过程的血脑屏障保护治疗。
核心结论
- sICH是急性缺血性卒中系统性溶栓少见但严重的并发症,及时诊断和早期纠正凝血障碍仍是治疗基石。
研究设计与样本
- 美国心脏协会/美国卒中协会组织写作组进行文献综述并达成共识的科学声明。
- 文献综述涵盖随机试验、前瞻性和回顾性研究、观点性文章、病例系列和病例报告。
主要发现
- sICH是急性缺血性卒中系统性溶栓少见但严重的并发症。
- 及时诊断和早期纠正阿替普酶后凝血障碍仍是治疗基石。
临床怎么用
- 对阿替普酶溶栓后sICH应及时诊断并早期纠正凝血障碍。
局限性
- sICH治疗基于专家意见和小型病例系列,疗效未充分确立。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Symptomatic intracranial hemorrhage (sICH) is the most feared complication of intravenous thrombolytic therapy in acute ischemic stroke. Treatment of sICH is based on expert opinion and small case series, with the efficacy of such treatments not well established. This document aims to provide an overview of sICH with a focus on pathophysiology and treatment. METHODS: A literature review was performed for randomized trials, prospective and retrospective studies, opinion papers, case series, and case reports on the definitions, epidemiology, risk factors, pathophysiology, treatment, and outcome of sICH. The document sections were divided among writing group members who performed the literature review, summarized the literature, and provided suggestions on the diagnosis and treatment of patients with sICH caused by systemic thrombolysis with alteplase. Several drafts were circulated among writing group members until a consensus was achieved. RESULTS: sICH is an uncommon but severe complication of systemic thrombolysis in acute ischemic stroke. Prompt diagnosis and early correction of the coagulopathy after alteplase have remained the mainstay of treatment. Further research is required to establish treatments aimed at maintaining integrity of the blood-brain barrier in acute ischemic stroke based on inhibition of the underlying biochemical processes.
引用
- Yaghi S, Willey JZ, Cucchiara B, et al. Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017. PMID: 29097489. doi:10.1161/STR.0000000000000152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。